ABT-263 (Navitoclax) 100mg | 98.02%
APEXBIO TECHNOLOGY LLC
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family
More Information Supplier PageABT-263 (Navitoclax)
Search Results
(-)-Warfarin 25 mg | ≥98%
Cayman Chemical
(-)-Warfarin
(-)-Warfarin 10 mg | ≥98%
Cayman Chemical
(-)-Warfarin
(-)-Warfarin 5 mg | ≥98%
Cayman Chemical
(-)-Warfarin
(-)-Warfarin 1 mg | ≥98%
Cayman Chemical
(-)-Warfarin
(-)-WAY 100135 dihydrochloride Please inquire | 99%
BOC Sciences
(-)-WAY 100135 dihydrochloride is a selective serotonin 5-HT1A antagonist.
More Information Supplier Page(-)-WIN 55,212-3 (mesylate) 50 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 (mesylate) 25 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 (mesylate) 10 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 (mesylate) 5 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 mesylate Please inquire | ≥98%
BOC Sciences
(−)-WIN 55,212-3 is an aminoalkylindole derivative which acts as a competitive neutral antagonist of the human cannabinoid CB2 receptor and presumably express the CB1 receptor. It also weakly antagonizes the melatonin MT1 and muscarinic M4 receptors but has no effect on several other G protein-coupled receptors.
More Information Supplier Page